Thanks to our funding partners, past and present
Current
NIH
2017-2022 R01 MH104030 – The New Tics Study: A Novel Approach to Pathophysiology and Cause of Tic Disorders (PI: Kevin Black and Bradley Schlaggar)
The Michael J. Fox Foundation for Parkinson’s Research
2017-2019 Dopamine buffering capacity measured by phMRI as a novel biomarker of disease progression in PD
Pharma
ACADIA Pharmaceuticals: Safety and Efficacy of Adjunctive Pimavanserin in Adults With Parkinson’s Disease and Inadequately Controlled Depression
Current collaborations
NIH
2016-2021 Early predictors of brain health and development in youth with T1DM (PI: Tamara Hershey)
Tourette Association of America
2015-2017 Network Architecture of the Brain in Tourette Syndrome and its Phenotypic Subgroups (PI: D. Greene)
2015-2018 Prevalence of TD and Tics among a Community-recruited Sample of Adults from Haiti (PI: C. Striley)
2015-2018 Testing a Pathophysiological Model of Complex Tics (PI: C. Richards)
Barnes-Jewish Hospital Foundation
2015-2018 Complex Effects of Dietary Manipulation on Metabolic Function, Inflammation and Health
Past
NIH
2015-2017 R21 NS091635 – Predicting outcome in children with new-onset tics using neuroimaging data (PI: Bradley Schlaggar and Kevin Black)
2012-2014 R21 MH098670 – Testing the phasic dopamine release hypothesis in Tourette syndrome: pilot (PI: Kevin Black and Tamara Hershey)
2009-2014 K24 MH087913 – Training new investigators in neuroimaging and in the neuropsychiatry of movement disorders
2009-2011 R21 MH081080 – Quantitative dopamine receptor pharmacodynamics from fMRI (and ARRA supplement)
2009 R13 NS066788 – 5th International Scientific Symposium on Tourette Syndrome
2008-2013 R01 NS058797 – Mapping mood in the subthalamic nucleus in PD (PI Tamara Hershey; KJB co-investigator)
2006-2011 R01 MH073856 – Dopaminergic effects on cortical function in Tourette’s
2002-2005 R01 NS044598 – Dopamine D1 effects on blood flow, metabolism, and BOLD
2001-2004 R21 NS042750 – Testing dopaminergic function using pharmacologic fMRI
1996-2001 K08 NS001898 – On-off mood change in Parkinson’s disease
Tourette Association of America
1998-1999 PET studies with NMB in Tourette Syndrome
2000-2001 A pilot study of levodopa for treatment of tics in children and adults
2003-2004 Levodopa-stimulated dopamine release (pilot)
2004-2005 Morphological abnormalities of the thalamus and basal ganglia in Tourette syndrome by computational anatomy (PI: L. Wang)
2005-2006 Levodopa-stimulated dopamine release II
2008-2009 Finding tics in the community without putting a doctor on every corner
2010-2011 Uncovering disparities in TS prevalence and identification between Caucasians and African-Americans (PI: C. Striley)
2010-2012 Tourette Syndrome Association neuroimaging consortium pilot
2015-2017 Network Architecture of the Brain in Tourette Syndrome and its Phenotypic Subgroups (PI: D. Greene)
2015-2017 Prevalence of TD and Tics among a Community-recruited Sample of Adults from Haiti (PI: C. Striley)
NARSAD
1999-2001 Levodopa activation fMRI study of Tourette syndrome
McDonnell Center for Systems Neuroscience at Washington University
2014-2015 A new collaboration with Abby Hollander, M.D.
2017 BIGTIC collaboration meeting
Barnes-Jewish Hospital Foundation
2015-2018 Complex Effects of Dietary Manipulation on Metabolic Function, Inflammation and Health (PI: S. Klein)